CBOE vs RPRX · P/E 24, rev $2.72B vs P/E 15, rev $1.30B
Cboe Global Markets Inc (CBOE) versus Royalty Pharma Plc (RPRX) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
Latest reported CBOE revenue for 2026-06-30 was $2.72B. Net income was $738.8M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Not investment advice. Open the CBOE and RPRX stock pages for the full models.
Not investment advice.